Investment

U-M commits $20m to four spinouts
University of Michigan has committed an initial $2.75m in combined funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.
Neuspera restimulates $26m series B
Neuspera Medical has secured a $12m extension to bring its series B round to the targeted $26m close, with all investors from the first tranche returning.
Centrica gives Mixergy a whirl
The energy supplier's corporate venturing subsidiary has put an undisclosed sum into Oxford's smart water boiler spinout Mixergy.
Phylagen traces corporates for $14m series A
The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.
Glycotest captures $3m from Fosun Pharma
The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.
Passage Bio follows $116m series A trajectory
Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.
Vor roars to $42m series A
Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.
Sitka sets up $1.2m
UBC and CDRD spinout Sitka Biopharma has now lured $5.5m in total and is readying its bladder cancer treatment for initial clinical trials.

Other News

Complion complies for $7m series B
Complion collected funding from investors including the multi-university-backed Ohio Innovation Fund for its regulatory compliance software platform catered to sites conducting clinical research.
OssDsign takes in $6.9m
Regenerative craniofacial implant manufacturer OssDsign has amassed $19.7m altogether as it prepares to take its products based on Karolinska and Uppsala university research into new markets.
MIT helps SendFriend to $1.7m
Founded out of Massachusetts Institute of Technology, SendFriend has built a blockchain-powered online payment transfer platform that uses technology provided by fintech developer Ripple.
6Estates tends to series B round
6Estates had previously raised $2m of funding for its market intelligence products based on research from NUS and Tsinghua University.
Nuvaira shares $79m series E news
Nuvaira, based on research by a then-professor at Washington University School of Medicine, has closed a $79m funding round led by US Venture Partners.
Kaust accelerator unveils third roster
Kaust is preparing for the third phase of its Taqadam startup accelerator, which is supported by a host of Saudi Arabian academic institutions and claims to have achieved a 35% female participation rate.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
2013-17 data review
Global University Venturing's data review and roundup of funds investing in spinouts and startups
test reg

Login